National Association of Testing Authorities, Australia
Scope of Accreditation
LSI Medience Corporation
Site
Anti-Doping Laboratory
Accreditation No.
14243
Site No.
14236
Date of Accreditation
09 Aug 1999
Contact
Ms Ayako Ikekita P: 81 359942360
Availability
Services conditionally available to external clients
Scope of Accreditation
Anti-Doping Laboratory
ISO/IEC 17025 (2017)
Legal - Analysis for compliance with WADA and sporting federation requirements
- This facility complies with the requirements of the World Anti-Doping Agency (WADA) International Standard for Laboratories (ISL) (January 2021)
Service | Product | Determinant | Technique | Procedure |
---|---|---|---|---|
Analysis for sports drugs and drug metabolites | Dried blood spots | S1: Anabolic agents | Derivatization; LC-MSn (n≥1) | in-house method TK-3B-39: Qualitative CP |
Dried blood spots; Human blood; Human urineHuman Blood cell fraction | M3 Gene and cell dopingDNA sequencing for VAR-EPO | Polymerase chain reaction (PCR)Polymerase chain reaction(PCR) /DNA sequencing | In-house method TK-3B-55 | |
Human blood | M1: Manipulation of blood and blood components (hemoglobin-based oxygen carriers) | Enzymatic digestion; LC-MSn (n≥1); Precipitation; Visual examination | in-house methods TK-3B-29: Qualitative CP, TK-3B-50:ITP | |
Blood parameters | Flow cytometry | in-house method TK-3B-27: Quantitative CP | ||
M3 Gene and cell doping | Polymerase chain reaction (PCR) | in-house method TK-3B-35:Qualitative CP | ||
M1: Manipulation of blood and blood components | Flow cytometry | in-house method TK-3B-28 ITP, Qualitative CP | ||
Human plasma; Human serum; Human urine | S2: Peptide hormones, growth factors, related substances, and mimetics (erythropoiesis stimulating agents - SAR-PAGE, IEF-PAGE) | Gel electrophoresis; Ultrafiltration (UF) | in-house methods TK-3B-13, TK-3B-36: ITP, Qualitative CP | |
Human serum | Human growth hormone (HGH) biomarkers; S2: Peptide hormones, growth factors, related substances, and mimetics | Chemiluminescent immunoassay; LC-HRMSn (n≥1); Precipitation | in-house methods TK-3B-52, TK-3B-53; ITP, Quantitative CP | |
S2: Peptide hormones, growth factors, related substances, and mimetics (human growth hormone - isoform) | Affinity-binding assay | in-house methods TK-3B-43: ITP, Quantitative CP | ||
S1: Anabolic agents (including steroid profiling) | LC-MSn (n≥1); Solid phase extraction (SPE) | in-house method TK-3B-47: ITP, Quantitative CP | ||
Human urine | S2: Peptide hormones, growth factors, related substances, and mimetics | Dilute and shoot; Enzymatic hydrolysis; Immunopurification; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE); Ultrafiltration (UF) | in-house methods TK-3B-06, TK3B-07: ITP TK-3B-15: Qualitative CP, TK-3B-12:Qualitative CP | |
S4: Hormone and metabolic modulators | Immunopurification; LC-HRMSn (n≥1); Ultrafiltration (UF) | In-house method TK-3B-12 Qualitative CP | ||
S8: Cannabinoids | Chemical hydrolysis; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods: TK-3B-06, TK-3B-10: ITP TK-3B-25:Quantitative CP, TK-3B-15:Qualitative CP | ||
S1: Anabolic agents (including steroid profiling) | Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); Gas chromatography - Combustion - Isotope ratio mass spectrometry (GC-C-IRMS); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods: TK-3B-06, TK-3B-10: ITP TK-3B-02, TK-3B-14, TK-3B-15, TK-3B-16,TK-3B-17, TK-3B-20, TK-3B-21: Qualitative CP TK-3B-19: Quantitative CP | ||
S4: Hormone and metabolic modulators | Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods TK-3B-06, TK-3B-08, TK-3B-10:ITP TK-3B-15, TK-3B-16; Qualitative CP | ||
S7: Narcotics | Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods TK-3B-06, TK-3B-08, TK-3B-10: ITP TK-3B-15, TK-3B-16;Qualitative CP TK-3B-26: Quantitative CP | ||
S9: Glucocorticoids | Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MS-MS; LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house method TK-3B-06:ITP TK-3B-15:Qualitative CP | ||
S2: Peptide hormones, growth factors, related substances, and mimetics (chorionic gonadotrophin and luteinizing hormone) | Affinity-binding assay | in-house methods TK-3B-09: ITP; TK-3B-18: Quantitative CP | ||
S3: Beta-2 agonists | Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house method TK-3B-06, TK-3B-10: ITP TK-3B-15, Qualitative CP TK-3B-23, TK-3B-24:Quantitative CP | ||
pH | Potentiometry | in-house method TK-3B-40 | ||
S6: Stimulants | Chiral separation; Derivatization; Dilute and shoot; Enzymatic hydrolysis; GC-HRMSn (n≥1); GC-MSn (n≥1); LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods TK-3B-06, TK-3B-08, TK-3B-10: ITP TK-3B-15, TK-3B-16: Qualitative CP TK-3B-22: Quantitative CP | ||
Specific gravity | Refractometry | in-house method TK-3B-41: ITP, Quantitative CP | ||
P1: Beta-blockers | Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods TK-3B-06: ITP TK-3B-15: Qualitative CP | ||
S5: Diuretics and masking agents | Dilute and shoot; Enzymatic hydrolysis; LC-HRMSn (n≥1); LC-MSn (n≥1); Liquid liquid extraction; Solid phase extraction (SPE) | in-house methods TK-3B-06, TK-3B-07:ITP TK-3B-15: Qualitative CP |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
14243
Site No.
14236
Print date
11 Nov 2024
END OF SCOPE